JPH10500129A - 片頭痛の治療におけるｎｏスカベンジャー、阻害剤または拮抗剤の使用 - Google Patents

片頭痛の治療におけるｎｏスカベンジャー、阻害剤または拮抗剤の使用

Info

Publication number
JPH10500129A
JPH10500129A JP7529495A JP52949595A JPH10500129A JP H10500129 A JPH10500129 A JP H10500129A JP 7529495 A JP7529495 A JP 7529495A JP 52949595 A JP52949595 A JP 52949595A JP H10500129 A JPH10500129 A JP H10500129A
Authority
JP
Japan
Prior art keywords
migraine
headache
active ingredient
nitric oxide
antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7529495A
Other languages
English (en)
Japanese (ja)
Inventor
ジェス、オルセン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPH10500129A publication Critical patent/JPH10500129A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
JP7529495A 1994-05-11 1995-05-10 片頭痛の治療におけるｎｏスカベンジャー、阻害剤または拮抗剤の使用 Pending JPH10500129A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT94610027.8 1994-05-11
EP94610027 1994-05-11
PCT/IB1995/000415 WO1995031195A1 (en) 1994-05-11 1995-05-10 Use of no scavengers, inhibitors or antagonists in the treatment of migraine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007057587A Division JP2007137906A (ja) 1994-05-11 2007-03-07 片頭痛の治療におけるｎｏスカベンジャー、阻害剤または拮抗剤の使用

Publications (1)

Publication Number Publication Date
JPH10500129A true JPH10500129A (ja) 1998-01-06

Family

ID=8218183

Family Applications (2)

Application Number Title Priority Date Filing Date
JP7529495A Pending JPH10500129A (ja) 1994-05-11 1995-05-10 片頭痛の治療におけるｎｏスカベンジャー、阻害剤または拮抗剤の使用
JP2007057587A Withdrawn JP2007137906A (ja) 1994-05-11 2007-03-07 片頭痛の治療におけるｎｏスカベンジャー、阻害剤または拮抗剤の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007057587A Withdrawn JP2007137906A (ja) 1994-05-11 2007-03-07 片頭痛の治療におけるｎｏスカベンジャー、阻害剤または拮抗剤の使用

Country Status (12)

Country Link
US (1) US6265441B1 (enExample)
EP (1) EP0758890B1 (enExample)
JP (2) JPH10500129A (enExample)
AT (1) ATE291909T1 (enExample)
AU (1) AU704059B2 (enExample)
CA (1) CA2189762C (enExample)
DE (1) DE69534118T2 (enExample)
DK (1) DK0758890T3 (enExample)
ES (1) ES2238074T3 (enExample)
PT (1) PT758890E (enExample)
SI (1) SI0758890T1 (enExample)
WO (1) WO1995031195A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515881A (ja) * 2004-10-07 2008-05-15 エヌジーイーエヌ・ファーマソーティカルズ・エヌ．ブイ． 安定化酸素放出組成物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270531C (en) * 1996-11-05 2011-08-30 Head Explorer Aps A method for treating tension-type headache
US6284794B1 (en) 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
AU1824300A (en) * 1998-11-23 2000-06-13 Linden Biotechnology, Inc. Combination products of a guanylate cyclase inhibitor and a local anesthetic forpain relief
US20060247216A1 (en) * 2002-10-25 2006-11-02 Haj-Yehia Abdullah I Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
EP1578413A2 (en) * 2002-11-29 2005-09-28 Yissum Research Development Company of The Hebrew University of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
WO2007009462A2 (en) * 2005-07-15 2007-01-25 Region Hovedstaden V/Glostrup Hospital Treatment of migraine and headaches
US20090191283A1 (en) * 2008-01-24 2009-07-30 Oronsky Bryan Todd Treatment of headaches, neck pain, joint pain and inflammatory-type pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
FR2707494B1 (fr) 1993-07-02 1995-08-25 Roussel Uclaf Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.
SK16396A3 (en) * 1993-08-12 1996-09-04 Astra Ab Amidine derivatives with nitric oxide synthetase activities
GB9317686D0 (en) 1993-08-25 1993-10-13 Johnson Matthey Plc Pharmaceutical compositions
EP0759027B1 (en) * 1994-05-07 1999-08-04 Astra Aktiebolag Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515881A (ja) * 2004-10-07 2008-05-15 エヌジーイーエヌ・ファーマソーティカルズ・エヌ．ブイ． 安定化酸素放出組成物

Also Published As

Publication number Publication date
EP0758890A1 (en) 1997-02-26
DK0758890T3 (da) 2005-04-18
US6265441B1 (en) 2001-07-24
AU704059B2 (en) 1999-04-15
SI0758890T1 (enExample) 2005-08-31
CA2189762A1 (en) 1995-11-23
CA2189762C (en) 2009-01-13
JP2007137906A (ja) 2007-06-07
AU2417995A (en) 1995-12-05
ES2238074T3 (es) 2005-08-16
DE69534118T2 (de) 2006-02-09
EP0758890B1 (en) 2005-03-30
DE69534118D1 (de) 2005-05-04
PT758890E (pt) 2005-06-30
ATE291909T1 (de) 2005-04-15
WO1995031195A1 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
EP0278821B1 (fr) Utilisation d'antagonistes de la morphine dans la préparation de médicaments à effet immunomodulateur et anti-viral, destinés notamment à traiter les états immuno-déficitaires acquis
JP2007137906A (ja) 片頭痛の治療におけるｎｏスカベンジャー、阻害剤または拮抗剤の使用
US20160340334A1 (en) Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids
US6565851B2 (en) Relieving symptoms of erectile dysfunction with proanthocyanidins
JPH11511174A (ja) 血管形成の促進方法
US20090098096A1 (en) Agent for correcting stress-inducing neuro-mediator, neuro-endocrine and metabolic disturbances and method for preventing and treating concomitant pathological conditions
EP4408412A1 (en) Compositions and methods for treating headaches
Kitamura et al. Nitric oxide-mediated retinal arteriolar and arterial dilatation induced by substance P.
AU743825B2 (en) Medicine containing yohimbine and arginine for treating erectile dysfunction
JPH0764748B2 (ja) 血栓症治療用組成物
US4880833A (en) Synergistic pharmaceutical compositions, their production and use
JP2872809B2 (ja) モノシアロガングリオシドｇｍ▲下１▼またはその誘導体を含有する，パーキンソン病の治療に適する医薬組成物
JPH0420409B2 (enExample)
US6075045A (en) Method of treating paralysis of the extremities caused by cerebral infarction
EP0413694B1 (fr) Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur
Grama et al. Effect of caffeine on pain management
CA1285880C (en) Use of terguride as a geriatric agent
CA2027593C (fr) Composition a activite anti-agregante plaquettaire utilisable en therapeutique
JPS63501360A (ja) 血栓性および血栓塞栓性疾患の治療のためのプロスタサイクリン、その類縁体またはプロスタグランジンおよびトロンボキサン類縁体
MXPA02008532A (es) Composicion para la prevencion y/o tratamiento de padecimientos vasculares, que comprende propionil l-carnitina y la coenzima q10.
US20050171030A1 (en) Relieving symptoms of erectile dysfunction and attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
JP2007536256A (ja) 心臓損傷の処置のためのピロロキノリンキノン薬およびその使用方法
JPWO2022056209A5 (enExample)
WO2025046207A1 (en) New use of a pde 5 inhibitor combination in promoting neurite outgrowth
Knudsen et al. Department of Medi cine Vanderbilt University Medical Center Nashville, TN 37232

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060704

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060710

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060829

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20061107